Scienture (SCNX) Expected to Post Earnings on Monday

Scienture (NASDAQ:SCNX) is expected to announce its Q2 2026 results before the market opens on Monday, August 17th. Analysts expect the company to post earnings of ($0.09) per share and revenue of $1.9640 million for the quarter. Investors may review the information on the company’s upcoming Q2 2026 earning report for the latest details on the call scheduled for Monday, August 17, 2026 at 4:00 PM ET.

Scienture (NASDAQ:SCNX) last posted its earnings results on Friday, May 15th. The company reported ($0.08) earnings per share for the quarter, beating the consensus estimate of ($0.23) by $0.15. The firm had revenue of $0.06 million during the quarter, compared to analysts’ expectations of $0.40 million.

Scienture Price Performance

Shares of NASDAQ SCNX opened at $0.38 on Monday. The business has a 50-day moving average price of $0.37 and a 200 day moving average price of $0.40. The stock has a market cap of $15.44 million, a PE ratio of -0.15 and a beta of 3.26. Scienture has a 52-week low of $0.24 and a 52-week high of $2.60.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Scienture in a report on Wednesday, June 24th. One analyst has rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, Scienture presently has a consensus rating of “Hold” and a consensus price target of $1.50.

Institutional Investors Weigh In On Scienture

An institutional investor recently bought a new stake in Scienture stock. Virtu Financial LLC purchased a new position in shares of Scienture Holdings, Inc. (NASDAQ:SCNX) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 89,930 shares of the company’s stock, valued at approximately $46,000. Virtu Financial LLC owned about 0.22% of Scienture as of its most recent SEC filing. Institutional investors own 5.68% of the company’s stock.

Scienture Company Profile

Scienture Holdings, Inc engages in the provision of health services and pharmaceutical products. It focuses on addressing underserved patients and indications through novel product concepts and innovation. The company was founded on July 15, 2005 and is headquartered in Lutz, FL.